(Q46469396)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

title

Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

author name string

Schuetz P

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Mueller B

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Dick W

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

Haas H

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

publication date

1 October 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

volume

43

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

11 January 2020

page(s)

604-610

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15867938%20AND%20SRC:MED&resulttype=core&format=json

Neurogenic heterotopic ossification in spinal cord injury.

11 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Para-Articular Ossification Following Hip Replacement:70 ArthroplastiesAD ModumMoore Using McFarland's Approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Incidence of heterotopic bone formation after major hip surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Progressive osseous heteroplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Fibrodysplasia ossificans progressiva, a heritable disorder of severe heterotopic ossification, maps to human chromosome 4q27-31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Bone cell differentiation and growth factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Effects of heterotopic bone formation on outcome after hip arthroplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Biochemical markers of bone turnover and development of heterotopic ossification after total hip arthroplasty.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

SAPHO syndrome treated with pamidronate: an open-label study of 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Pamidronate: a novel treatment for the SAPHO syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis: comment on the article by Maksymowyc

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Efficacy of pamidronate in complex regional pain syndrome type I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Myositis ossificans circumscripta of the knee improved by alendronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Myositis ossificans progressiva (Munchmeyer's disease). Brief review with report of two cases treated with corticosteroids and observed for 16 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

New Insights Into the Molecular Mechanisms of Action of Bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Bisphosphonates: from the laboratory to the clinic and back again

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Intravenously administered pamidronate in the treatment of Paget's disease of bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Risedronate and pamidronate treatment in the clinical management of patients with severe Paget's disease of bone and acquired resistance to bisphosphonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Bisphosphonates for the treatment of Charcot neuroarthropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Adverse effects of bisphosphonates. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Bisphosphonate-induced osteopetrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Effect of intravenous pamidronate on bone markers and local bone mineral density in fibrous dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Effect of liposomal and free bisphosphonates on the IL-1 beta, IL-6 and TNF alpha secretion from RAW 264 cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

Osteogenic induction in hereditary disorders of heterotopic ossification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Genetic transmission of fibrodysplasia ossificans progressiva. Report of a family

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Bone morphogenetic protein-4 regulation in fibrodysplasia ossificans progressiva

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Heterotopic ossification

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Evaluation and management of heterotopic ossification in patients with spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Preoperative irradiation versus the use of nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification following total hip replacement: the results of a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Prevention of heterotopic bone formation after total hip arthroplasty: a prospective randomised study comparing postoperative radiation therapy with indomethacin medication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Heterotopic ossification after hip and knee arthroplasty: risk factors, prevention, and treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Prevention of heterotopic bone formation in high risk patients post-total hip arthroplasty

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Early, wide excision of heterotopic ossification in the medial elbow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

The effect of etidronate on late development of heterotopic ossification after spinal cord injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

The effects of disodium ethane-1-hydroxy-1, 1-diphosphonate on adjuvant induced arthritis in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021

Heterotopic ossification following hip replacement or spinal cord injury. Two clinical studies with EHDP

1 reference

https://api.crossref.org/works/10.1038%2FSJ.SC.3101761

7 January 2021